Reporter is a synthes employee.Part: 357.133 lot: 3030229 manufacturing site: (b)(4).Release to warehouse date: january 21, 2009.The device history record shows this lot of was processed through the normal manufacturing and inspection operations with no rework or nonconformities noted.This lot met all dimensional, visual and packaging criteria at the time of release with no issues documented during the manufacturing process.Review of the device history record showed that there were no issues during the manufacture of this product which would contribute to this complaint condition.Visual inspection: the complaint device extraction scr for ti fem & tib nail (product code: 357.133, lot number: 3030229) was returned to customer quality (cq) west chester for investigation.The extraction screw tip severely damaged with threads peeling off the device.The device had deformed and started to corrode.According to procedure, these issues are identified as end of life indicators for the device.Device/defect identified: yes document /specification review: based on the date of manufacture, the current and manufactured version of the drawings were reviewed.Dimensional inspection: this was not performed as the defects identified are consistent with failure associated with use of the device.Complaint confirmed: complaint can be confirmed based on the available information.Conclusion: the item had been worn due to usage and according to procedure no further investigation is needed on the device as this is end life for the extraction screw.There was no indication that a design or manufacturing issue contributed to the complaint.No design issues were observed during the document/specification review.Based on the investigation findings, it has been determined that no corrective and/or preventative action is proposed.Additional monitoring for any potential safety signals will be conducted through complaint trending and other post-market safety surveillance activities.Device was used for treatment, not diagnosis.If information is obtained that was not available for the initial medwatch, a follow-up medwatch will be filed as appropriate.
|